- Home
- ALGS vs BDMD Comparison
ALGS vs BDMD Comparison
Compare ALGS & BDMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- BDMD
- Stock Information
- Founded
- ALGS 2018
- BDMD 2012
- Country
- ALGS United States
- BDMD China
- Employees
- ALGS N/A
- BDMD N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- BDMD
- Sector
- ALGS Health Care
- BDMD
- Exchange
- ALGS Nasdaq
- BDMD NYSE
- Market Cap
- ALGS 118.8M
- BDMD 106.4M
- IPO Year
- ALGS 2020
- BDMD N/A
- Fundamental
- Price
- ALGS $39.84
- BDMD $1.83
- Analyst Decision
- ALGS Strong Buy
- BDMD
- Analyst Count
- ALGS 1
- BDMD 0
- Target Price
- ALGS $75.00
- BDMD N/A
- AVG Volume (30 Days)
- ALGS 428.8K
- BDMD 82.9K
- Earning Date
- ALGS 11-06-2024
- BDMD 01-01-0001
- Dividend Yield
- ALGS N/A
- BDMD N/A
- EPS Growth
- ALGS N/A
- BDMD 578.78
- EPS
- ALGS N/A
- BDMD 0.43
- Revenue
- ALGS $5,997,000.00
- BDMD $33,048,249.00
- Revenue This Year
- ALGS N/A
- BDMD N/A
- Revenue Next Year
- ALGS N/A
- BDMD N/A
- P/E Ratio
- ALGS N/A
- BDMD $4.29
- Revenue Growth
- ALGS N/A
- BDMD N/A
- 52 Week Low
- ALGS $6.76
- BDMD $1.42
- 52 Week High
- ALGS $41.64
- BDMD $13.52
- Technical
- Relative Strength Index (RSI)
- ALGS 80.76
- BDMD N/A
- Support Level
- ALGS $28.00
- BDMD N/A
- Resistance Level
- ALGS $35.89
- BDMD N/A
- Average True Range (ATR)
- ALGS 4.05
- BDMD 0.00
- MACD
- ALGS 0.51
- BDMD 0.00
- Stochastic Oscillator
- ALGS 89.77
- BDMD 0.00
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About BDMD BAIRD MEDICAL INVESTMENT HLDGS LTD
Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.